IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.165
+0.045 (4.02%)
Aug 15, 2025, 10:32 AM - Market open
IRIDEX Employees
IRIDEX had 93 employees as of December 28, 2024. The number of employees decreased by 18 or -16.22% compared to the previous year.
Employees
93
Change (1Y)
-18
Growth (1Y)
-16.22%
Revenue / Employee
$534,882
Profits / Employee
-$58,570
Market Cap
19.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 93 | -18 | -16.22% |
Dec 30, 2023 | 111 | -19 | -14.62% |
Dec 31, 2022 | 130 | 11 | 9.24% |
Jan 1, 2022 | 119 | 30 | 33.71% |
Jan 2, 2021 | 89 | -5 | -5.32% |
Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IRIX News
- 2 days ago - IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Iridex Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema - GlobeNewsWire
- 3 months ago - IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Iridex Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - IRIDEX Changes Course - Seeking Alpha
- 3 months ago - Iridex to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 4 months ago - IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) - Seeking Alpha